Our Pipeline of Therapeutic Candidates

Development Timeline

Product Discovery Preclinical Phase I Phase II Phase III

CB-24

CB-4

CB-6

CB-25

Cancer Detection

A clinical-stage biopharmaceutical company developing first-in-class venom-derived peptide therapies to transform patient outcomes.

Company

Our Pipeline Clinical Trials CB-24 Mode of Action Scientific Reviews The Team

Investors

Investor Relations Press Release Events

Contact

Get in Touch

Privacy Policy